EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Host–microbiome interactions in leukemia: mechanisms, treatment response, and clinical implications

Jhommara Bautista, Rudy Carrión-Ruiz, Arianna Bourne-Cabezas, Luis Ayala Robles, Ana Maria Velez-Navarrete, Andrés López-Cortés

Frontiers in Cellular and Infection Microbiology · 08.07.2026 · 16

DOI: 10.3389/fcimb.2026.1842279 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Frontiers in Cellular and Infection Microbiology, online erschienen am 08.07.2026. Verfasst von Jhommara Bautista und 5 weiteren Autor:innen. Beteiligte Einrichtung: Cancer Research Group (CRG), Faculty of Medicine, Universidad de Las Américas, Quito, Ecuador. Hauptthemen laut MEDLINE: Leukemia, Host Microbial Interactions, Gastrointestinal Microbiome, Microbiota. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 120 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Host-microbiome interactions regulate immune function, epithelial barrier integrity, and hematopoietic homeostasis. Intestinal microbial communities show consistent disruption in leukemia, particularly during intensive chemotherapy and hematopoietic stem cell transplantation. Reduced microbial diversity, depletion of short-chain fatty acid (SCFA)–producing commensals, and expansion of opportunistic taxa are recurrent findings across cohorts. Such patterns correlate with inflammatory signaling, impaired barrier function, and shifts in immune responses affecting treatment tolerance and hematopoietic recovery. Clinical associations show greater consistency for treatment-related outcomes, including infection risk, mucosal injury, and delayed immune reconstitution, than for leukemogenesis. Evidence supporting a direct causal role of specific microbial taxa in disease initiation remains limited. This review examines microbiome composition, microbial taxa, and mechanistic pathways in leukemia, with emphasis on how microbiome alterations may influence leukemia biology, disease progression, treatment response, and clinical outcomes, while acknowledging that most human evidence remains associative.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LeukemiaHost Microbial InteractionsGastrointestinal MicrobiomeMicrobiotaHumansAnimalsIntestinal Barrier FunctionHomeostasisHematopoietic Stem Cell Transplantation

Stichwörter der Autor:innen

epithelial barrier integrityhematopoietic homeostasisimmune functionleukemiamicrobiome

Autor:innen und Institutionen

  • Cancer Research Group (CRG), Faculty of Medicine, Universidad de Las Américas, Quito, Ecuador.
  • Hospital de Especialidades Carlos Andrade Marín, Quito, Ecuador.
  • Sociedad Ecuatoriana de Hematología, Quito, Ecuador.

Zitieren

APA

Bautista, J., Carrión-Ruiz, R., Bourne-Cabezas, A., Robles, L. A., Velez-Navarrete, A. M., & López-Cortés, A. (2026). Host–microbiome interactions in leukemia: mechanisms, treatment response, and clinical implications. Frontiers in Cellular and Infection Microbiology, 16. https://doi.org/10.3389/fcimb.2026.1842279

Vancouver

Bautista J, Carrión-Ruiz R, Bourne-Cabezas A, Robles LA, Velez-Navarrete AM, López-Cortés A. Host–microbiome interactions in leukemia: mechanisms, treatment response, and clinical implications. Frontiers in Cellular and Infection Microbiology. 2026;16. doi:10.3389/fcimb.2026.1842279

BibTeX
@article{Bautista2026,
  author = {Bautista, Jhommara and Carrión-Ruiz, Rudy and Bourne-Cabezas, Arianna and Robles, Luis Ayala and Velez-Navarrete, Ana Maria and López-Cortés, Andrés},
  title = {Host–microbiome interactions in leukemia: mechanisms, treatment response, and clinical implications},
  journal = {Frontiers in Cellular and Infection Microbiology},
  year = {2026},
  volume = {16},
  doi = {10.3389/fcimb.2026.1842279}
}
Kostenlos starten →